M
Mounira Smati-Lafarge
Publications - 6
Citations - 678
Mounira Smati-Lafarge is an academic researcher. The author has contributed to research in topics: Serology & Medicine. The author has an hindex of 4, co-authored 5 publications receiving 372 citations.
Papers
More filters
Journal ArticleDOI
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
Delphine Planas,Delphine Planas,Timothée Bruel,Timothée Bruel,Ludivine Grzelak,Florence Guivel-Benhassine,Florence Guivel-Benhassine,Isabelle Staropoli,Isabelle Staropoli,Françoise Porrot,Françoise Porrot,Cyril Planchais,Julian Buchrieser,Julian Buchrieser,Maaran Michael Rajah,Elodie Bishop,Mélanie Albert,Mélanie Albert,Flora Donati,Flora Donati,Matthieu Prot,Sylvie Behillil,Sylvie Behillil,Vincent Enouf,Vincent Enouf,Marianne Maquart,Mounira Smati-Lafarge,Emmanuelle Varon,Frédérique Schortgen,Layla Yahyaoui,María González,Jérôme De Seze,Hélène Péré,David Veyer,Aymeric Sève,Etienne Simon-Loriere,Samira Fafi-Kremer,Karl Stefic,Hugo Mouquet,Laurent Hocqueloux,Sylvie van der Werf,Sylvie van der Werf,Thierry Prazuck,Olivier Schwartz,Olivier Schwartz +44 more
TL;DR: In this paper, the sensitivity of the two variants to SARS-CoV-2 antibodies present in sera and nasal swabs from individuals infected with previously circulating strains or who were recently vaccinated, in comparison with a D614G reference virus was examined.
Journal ArticleDOI
Systematic Severe Acute Respiratory Syndrome Coronavirus 2 Screening at Hospital Admission in Children: A French Prospective Multicenter Study.
Julie Poline,Jean Gaschignard,Claire Leblanc,Fouad Madhi,Elsa Foucaud,Elodie Nattes,Albert Faye,Stéphane Bonacorsi,Patricia Mariani,Emmanuelle Varon,Mounira Smati-Lafarge,Marion Caseris,Romain Basmaci,Noémie Lachaume,Naim Ouldali +14 more
TL;DR: To limit intra-hospital transmission, a systematic screening of children admitted to hospital should be considered, and a symptom-based SARS-CoV-2 testing strategy failed to identify 45% (95%CI [24; 68]) of hospitalized children infected by Sars-Cov-2.
Posted ContentDOI
Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic
Robert M. Cohen,Camille Jung,Naim Ouldali,Aurelie Sellam,Christophe Batard,Fabienne Cahn-Sellem,Annie Elbez,Alain Wollner,O. Romain,François Corrard,Said Aberrane,Nathalie Soismier,Rita Creidy,Mounira Smati-Lafarge,Odile Launay,Stéphane Béchet,Emmanuelle Varon,Corinne Levy +17 more
TL;DR: In area heavily affected by COVID-19, after the peak of the first epidemic wave and during the lockdown, the rate of children with positive SARS-CoV-2 RT-PCR was very low, but the rates of positive on serology was higher, suggesting a low risk of transmission.
Journal ArticleDOI
Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: A cross-sectional study
Robert Cohen,Camille Jung,Naim Ouldali,Aurelie Sellam,Christophe Batard,Fabienne Cahn-Sellem,Annie Elbez,Alain Wollner,O. Romain,François Corrard,Said Aberrane,Nathalie Soismier,Rita Creidy,Mounira Smati-Lafarge,Odile Launay,Stéphane Béchet,Emmanuelle Varon,Corinne Levy +17 more
TL;DR: In this article, the spread of SARS-CoV-2 was examined in children in the most affected region in France, Paris, during the COVID-19 epidemic.
Journal ArticleDOI
Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021
Clémentine Calba,Aurélien Zhu-Soubise,Sarah Mahdjoub-Assaad,Berenice Villegas-Ramirez,Arnaud Tarantola,Delphine Barataud,Lisa King,Esra Morvan,Anne Guinard,Olivier Catelinois,Damien Mouly,Guillaume Spaccaferri,Alexandra Mailles,Sibylle Bernard-Stoecklin,Muriel Beliah-Nappez,Aurélie Misme,Diane Descamps,Amine Si Ali,Valérie Garrait,Mounira Smati-Lafarge,Marilyne Gojon,Lucile Trutt,Blandine De Kerros,Josselin Vincent,Colin Deschanvres,Simon Ribes,Florence Daubresse,Olivier Glass,Valérie Lebaillif,Karine Vilhes,Jacques Izopet,Sylvie van der Werf,Sylvie Behillil,Etienne Simon-Loriere,Vincent Enouf +34 more
TL;DR: Two confirmed SARS-CoV-2 infection with the B.1.351 variant were reported in France in mid-January, 2020 as discussed by the authors, and these cases attended a gathering in Mozambique in mid December 2020.